What is Same-Store Sales Growth?

Same-Store Sales Growth (SSSG) is a critical financial metric that measures the percentage change in revenue generated by retail locations that have been open for at least one full year, comparing performance over equivalent time periods. In the cannabis industry, this metric is particularly valuable for evaluating the operational efficiency and market penetration of dispensaries and retail chains without the distortion of new store openings. For cannabis companies, SSSG provides insight into whether existing locations are gaining or losing market share in their local markets. A positive SSSG indicates that established dispensaries are growing their customer base, increasing average transaction values, or successfully introducing new products. Conversely, negative SSSG may signal increased competition, market saturation, or operational challenges. The cannabis industry has seen varying SSSG performance across different markets and operators. For example, multi-state operators (MSOs) like Curaleaf and Green Thumb Industries regularly report SSSG figures in their quarterly earnings, with mature markets typically showing more modest growth compared to newly launched operations. During 2022-2023, many established cannabis retailers experienced SSSG challenges due to increased competition from new license holders and market maturation in states like California and Colorado. SSSG is calculated by comparing revenue from stores open for the same periods in consecutive years, excluding any locations that opened, closed, or underwent significant renovations during the comparison period. This standardization allows investors and analysts to assess management effectiveness, brand strength, and market positioning without the noise of expansion activities. For publicly traded cannabis companies, consistent positive SSSG often correlates with stronger stock performance and indicates sustainable business models in an increasingly competitive landscape. *Disclaimer: This information is for educational purposes only and does not constitute investment advice. Cannabis investments carry significant risks including regulatory changes and market volatility.*